Important Safety Information: CERDELGA can affect how other medicines work and other medicines can affect how CERDELGA works. Especially tell your doctor if you take St. John's Wort (Hypercium perforatum) or medicines for fungal infections, tuberculosis, seizures, heart rhythm and rate problems, high blood pressure, or depression. Tell your doctor about all of your medical conditions, including history of heart attacks or heart rhythm problems. View more

Sanofi Genzyme Support Services

Patient Services

Sanofi Genzyme Case Managers provide free and voluntary care coordination, support and services to individuals living with Gaucher disease who reside in the United States. Sanofi Genzyme Case Managers are professionals with experience in the health care industry who are committed to helping individuals connect with the resources available to them.

Whether you have just been diagnosed with Gaucher disease and are exploring treatment with Cerdelga or you are considering resuming treatment, Sanofi Genzyme Case Managers are available to assess your unique situation and help answer any questions you may have, including by helping you understand your insurance options for treatment with Cerdelga. Our confidential services are offered at no cost to you and are completely voluntary.


Dedicated Case Management Support

If you decide to take advantage of Sanofi Genzyme’s support services, you will have access to your own personal Case Manager, someone who will get to know you and will tailor his or her services to meet your specific needs.

Sanofi Genzyme Case Managers are aligned regionally, so you will work with someone who is familiar with local resources and understands your state’s insurance regulations. Our Case Managers can also help you find medical experts in your area.


Working Together

Your Sanofi Genzyme Case Manager will partner with you as you take the journey from diagnosis to treatment plan and help you navigate any bumps along the way. Working closely with you and your family, your health care providers and insurance company, your Sanofi Genzyme Case Manager will help coordinate access to treatment with Cerdelga by providing:


Contact a Sanofi Genzyme Case Manager

A Sanofi Genzyme Case Manager is only a click or phone call away from answering your questions and working with you to help address your needs.

Connect with a Sanofi Genzyme Case Manager online at genzymesupportservices.com

Or call 1-800-745-4447, Option 3
Monday through Friday, 8:00 AM to 6:00 PM EST

Spanish-speaking Case Managers are available, as well as interpreters for other languages.


Indication & Usage

CERDELGA (eliglustat) capsules is a glucosylceramide synthase inhibitor indicated for the long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test.

Limitations of Use:

Important Safety Information

CERDELGA is contraindicated in EMs or IMs taking a strong or moderate CYP2D6 inhibitor concomitantly with a strong or moderate CYP3A inhibitor, and in IMs or PMs taking a strong CYP3A inhibitor due to the risk of significantly increased eliglustat blood concentration, which may result in prolongation of cardiac intervals that could result in cardiac arrhythmias.

Your doctor will perform a test to help determine if CERDELGA is right for you.

CERDELGA can affect the way other medicines work and other medicines can affect how CERDELGA works. Using CERDELGA with other medicines or herbal supplements (including St. John’s Wort) may cause an increased risk of side effects, including ECG changes and irregular heart beat. Especially tell your doctor if you take medicines for fungal infections, tuberculosis, seizures, heart rhythm and rate problems, high blood pressure, or depression or other mental health problems. Your doctor may need to prescribe a different medicine, change your dose of other medicines, or change your dose of CERDELGA. Tell your doctor about any new medicines before you start taking them.

Before taking CERDELGA, tell your doctor about all of your medical conditions, including kidney or liver problems, history of heart attacks, or heart rhythm problems (including long QT syndrome). If you are pregnant or plan to become pregnant or breastfeed, talk to your physician. It is not known if CERDELGA will harm your unborn baby.

It is not known if CERDELGA is safe and effective in children.

Swallow the capsule whole, preferably with water. If you miss a dose of CERDELGA, take the next dose at the usual time. Do not take two doses of CERDELGA at the same time. Avoid eating or drinking grapefruit products while taking CERDELGA. Grapefruit products can increase the amount of CERDELGA in your body.

The most common adverse reactions (≥10%) for CERDELGA are: fatigue, headache, nausea, diarrhea, back pain, pain in extremities, and upper abdominal pain. Call your doctor for medical advice about adverse effects.

You may report adverse effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

If you would like more information, talk with your doctor. You may also go to www.cerdelga.com for the Full Prescribing Information, including the Patient Medication Guide, or call Sanofi Genzyme at 1-800-745-4447.